Vaxxinity Stock Price, News & Analysis
Company Description
Vaxxinity (OTC Link: VAXX) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $13.9M, ranking #6,296 among all listed U.S. companies by market cap.
VAXX stock has declined 50.0% over the past year. Shares last traded at $0.0001.
On a trailing twelve-month basis, Vaxxinity reported net income of -$56.9M and diluted earnings per share of $-0.45.
This page provides a comprehensive overview of VAXX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vaxxinity (VAXX) stock last traded at $0.0001. Over the past 12 months, the stock has lost 50.0%. At a market capitalization of $13.9M, VAXX is classified as a micro-cap stock with approximately 126.8M shares outstanding.
Latest News
Vaxxinity has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include conferences, clinical trial, earnings. View all VAXX news →
SEC Filings
Financial Highlights
operating income reached -$58.3M, and net income was -$56.9M. Diluted earnings per share stood at $-0.45. The company generated -$57.2M in operating cash flow. With a current ratio of 1.89, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Vaxxinity (VAXX) currently stands at 169.6 thousand shares, representing 0.2% of the float. Over the past 12 months, short interest has decreased by 35.1%. This relatively low short interest suggests limited bearish sentiment. With 12.4 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Vaxxinity (VAXX) currently stands at 12.4 days, down 55% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has decreased 45.5% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 2.7 to 437.6 days.
VAXX Company Profile & Sector Positioning
Vaxxinity (VAXX) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the OTC Link.
Investors comparing VAXX often look at related companies in the same sector, including Biophytis Sa (BPTSY), Orgenesis Inc (ORGS), Kane Biotech Inc (KNBIF), Bioxytran Inc (BIXT), and ASEP MED HLDGS INC (SEPSF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VAXX's relative position within its industry.